BamSEC and AlphaSense Join Forces
Learn More

Crescent Biopharma Inc.

NASDAQ: CBIO    
Share price (10/21/25): $12.65    
Market cap (10/21/25): $176 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.6
from 8-K 13 pages Crescent Biopharma, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a Non-Voting Convertible Preferred Shares
12/34/56
EX-3.5
from 8-K 15 pages Glycomimetics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a Non-Voting Convertible Preferred Stock Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.4
from 8-K 30 pages The Companies Act (As Amended) Company Limited by Shares Memorandum of Association of Crescent Biopharma, Inc. Ref: Me/Kg/C9608-195644 the Companies Act (As Amended) Company Limited by Shares Memorandum of Association of Crescent Biopharma, Inc
12/34/56
EX-3.3
from 8-K 2 pages Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Glycomimetics, Inc
12/34/56
EX-3.2
from 8-K 2 pages Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Glycomimetics, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Glycomimetics, Inc
12/34/56
EX-3.7
from S-4 15 pages Crescent Biopharma, Inc. Bylaws Adopted September 19, 2024
12/34/56
EX-3.6
from S-4 24 pages ​ Certificate of Incorporation of Crescent Biopharma, Inc
12/34/56
EX-3.1
from DEFA14A 14 pages Glycomimetics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a Non-Voting Convertible Preferred Stock Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 8-K 14 pages Glycomimetics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a Non-Voting Convertible Preferred Stock Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.2
from 8-K ~1 page Certificate of Amendment to the Certificate of Incorporation of Glycomimetics, Inc
12/34/56
EX-3.1
from 8-K ~1 page Certificate of Amendment to the Certificate of Incorporation of Glycomimetics, Inc
12/34/56
EX-3.2
from 8-K 25 pages Amended and Restated Bylaws of Glycomimetics, Inc. (A Delaware Corporation) January 15, 2014 Glycomimetics, Inc. Amended and Restated Bylaws
12/34/56
EX-3.1
from 8-K 5 pages Glycomimetics, Inc. Amended and Restated Certificate of Incorporation * * * *
12/34/56
EX-3.2
from S-1/A 2 pages Certificate of Amendment to Amended and Restated Certificate of Incorporation of Glycomimetics, Inc
12/34/56
EX-3.5
from S-1 25 pages Amended and Restated Bylaws of Glycomimetics, Inc. (A Delaware Corporation) [—], 2013 Glycomimetics, Inc. Amended and Restated Bylaws
12/34/56
EX-3.4
from S-1 15 pages Glycomimetics, Inc. Amended and Restated Bylaws Adopted as of May 20, 2003
12/34/56
EX-3.3
from S-1 5 pages Glycomimetics, Inc. Amended and Restated Certificate of Incorporation I
12/34/56
EX-3.1
from S-1 17 pages Amended and Restated Certificate of Incorporation of Glycomimetics, Inc
12/34/56
EX-3
from DRS 15 pages Glycomimetics, Inc. Amended and Restated Bylaws Adopted as of May 20, 2003
12/34/56